Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
Beschreibungen/Notizen
Conformationally constrained analogues of the GPIIb/IIIa antagonist elarofiban (RWJ-53308) have been synthesized and biologically evaluated. The 1,2,4-triazolo[3,4-
a]pyridine scaffold provided potent antagonists with favorable pharmacodynamic and pharmacokinetic attributes in dogs. Compounds
12a and
13a exhibited enhancements in oral bioavailability,
t
1/2, and ex vivo duration of action (inhibition of ADP-induced platelet aggregation) relative to elarofiban.
Conformationally constrained triazolopyridine analogues of elarofiban were prepared, leading to compounds with improved pharmacodynamic and pharmacokinetic properties.